Sarcoma  >>  Beleodaq (belinostat)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Beleodaq (belinostat) / Aurobindo, Assertio
NCT00878800 / 2006-004345-42: A Phase I/II Clinical Trial of PXD101 in Combination With Doxorubicin in Patients With Soft Tissue Sarcomas

Checkmark For soft tissue sarcoma at ASCO 2015
May 2015 - May 2015: For soft tissue sarcoma at ASCO 2015
Completed
1/2
41
Europe
PXD101, PXD101 (Belinostat), Doxorubicin, Doxorubicin (Adriamycin)
Onxeo, Spectrum Pharmaceuticals, Inc
Dose Escalation: Solid Tumors, MTD: Soft Tissue Sarcomas
10/12
10/12

Download Options